Novarad HoloLens AR surgical navigation system VisAR receives approval from Indonesian FDA

(Nweon May 16, 2023) Novarad recently stated that VisAR, an AR surgical navigation system that can be used with Microsoft HoloLens, has been approved by the Indonesian Food and Drug Administration to support spinal surgery applications.

According to reports, VisAR is built on the Novarad imaging technology solution stack, providing interoperability, HIPAA compliance, image management and in-depth security. This end-to-end solution provides capabilities such as preoperative planning, virtual annotation, segmentation and bidirectional imaging.

In addition, Novarad has partnered with Microsoft to allow doctors wearing HoloLens 2 to convert patient imaging data into three-dimensional holograms and overlay them on the patient with sub-millimeter precision.

This allows the surgeon to focus directly on the surgical goal without having to turn to look at another flat screen as before. In this way, VisAR improves the accuracy and economy of surgical guidance. The team noted that for the HoloLens 2 VisAR solution, operating room setup time was less than 2 minutes, and pedicle screw placement achieved surgical accuracy of 2 mm in both open and minimally invasive surgery (MIS) procedures.

Novarad commented: “We are very excited to bring VisAR’s revolutionary technology to Indonesia. This demonstrates its innovative design and ability to improve patient outcomes. This technology will help Indonesian surgeons achieve higher accuracy with perform complex surgeries with lower risk and ultimately benefit the patient.”

The above is the detailed content of Novarad HoloLens AR surgical navigation system VisAR receives approval from Indonesian FDA. For more information, please follow other related articles on the PHP Chinese website!